| For: | Wang YT, Zhang Y, Tang T, Luo C, Liu MY, Xu L, Wang L, Tang XM. Anti-nuclear matrix protein 2+ juvenile dermatomyositis with severe skin ulcer and infection: A case report and literature review. World J Clin Cases 2022; 10(11): 3579-3586 [PMID: 35611208 DOI: 10.12998/wjcc.v10.i11.3579] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i11/3579.htm |
| Number | Citing Articles |
| 1 |
Seher Sener, Veysel Cam, Seza Ozen, Ezgi Deniz Batu. Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature. Seminars in Arthritis and Rheumatism 2024; 66 doi: 10.1016/j.semarthrit.2024.152426
|
| 2 |
Ichiro Kobayashi. Advances in Juvenile Dermatomyositis: Pathophysiology, Diagnosis, Treatment and Interstitial Lung Diseases—A Narrative Review. Children 2024; 11(9) doi: 10.3390/children11091046
|
| 3 |
Caroline Wald, Jan-Christoph Simon, Regina Treudler. Kutane Ulzerationen bei Dermatomyositis. Die Dermatologie 2025; 76(2) doi: 10.1007/s00105-024-05462-0
|
| 4 |
Sylwia Skraińska, Agnieszka Kiedik, Julia Kozłowska, Kacper Zima, Zuzanna Pietruk, Jakub Chamier-Gliszczyński, Dominik Płaza, Przemysław Siemiątkowski. MANIFESTATIONS OF THE SKIN IN DERMATOMYOSITIS AND THEIR DIAGNOSTIC SIGNIFICANCE: A LITERATURE REVIEW. International Journal of Innovative Technologies in Social Science 2026; 5(2(50)) doi: 10.31435/ijitss.2(50).2026.5370
|
| 5 |
Oana Buzoianu, Özlem Satirer, Jasmin B. Kuemmerle-Deschner, Christiane Reiser. Towards New Strategies: Case Report and Review of the Literature—Effective Use of JAK Inhibitor Baricitinib in a 4-Year-Old Boy with Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis. Journal of Clinical Medicine 2026; 15(2) doi: 10.3390/jcm15020709
|
| 6 |
|